DESIGN AND DEVELOPMENT OF MARKER ACTIVATED NANOMACHINES USING DNA ORIGAMI FOR CANCER THERAPY
Selective DNA-machine for SNP Detection in KRAS
Patra C.K., Smirnov V.V., Drozd V.S., Hussein Z., Rybalko D.S., Kozlova A.V., Nour M., Zemerova T.P., Kolosova O.S., Kalnin A.Y., El-Deeb A. Towards the Development of a DNA Automaton: Modular RNA-cleaving Deoxyribozyme Logic Gates Regulated by miRNAs. Analyst. 2024. Vol. 149. No. 6. pp. 1947-1957.
Nour M., Drozd V.S., Lemeshko E.A., Tafran L., Salimova A.A., Kulikova A.V., Eldeeb A.A. RNase H-dependent DNA thresholder modulated by cancer marker concentration. Chemical Communications. 2024. Vol. 60. No. 33. pp. 4427-4430.
Dubovichenko M.V., Nedorezova D.D., Eldeeb A.A., Nour M.A., Bobkov G.A., Ashmarova A.I., Kalnin A.Y., Kolpashchikov D.M. Cleaving Folded RNA by Multifunctional DNAzyme Nanomachines. Chemistry - A European Journal. 2024. pp. Accepted Articles.
Antisense Oligonucleotides-Mediated Gene Silencing for Cancer Therapy
Nedorezova D.D., Dubovichenko M.V., Kalnin A.Y., Nour M.A., Eldeeb A.A., Ashmarova A.I., Kurbanov G.F., Kolpashchikov D.M. Cleaving Folded RNA with DNAzyme Agents. ChemBioChem. 2024. Vol. 25. No. 1. pp. e202300637.
OPTIMIZATION OF AFFINITY AND STABILITY OF SELECTED APTAMER FOR BSA
Dubovichenko M.V., Batsa M., Bobkov G.A., Vlasov G.S., El-Deeb A.A., Kolpashchikov D.M. Multivalent DNAzyme agents for cleaving folded RNA. Nucleic Acids Research. 2024. Vol. 52. No. 10. pp. 5866–5879.
Ultrasensitive-selective DNA nanomachine for Teaticular Germ Cell Tumors detection
Hussein Z., Nour M., Kozlova A.V., Kolpashchikov D.M., Komissarov A., El-Deeb A. DNAzyme Nanomachine with Fluorogenic Substrate Delivery Function: Advancing Sensitivity in Nucleic Acid Detection. Analytical Chemistry. 2023. Vol. 95. No. 51. pp. 18667-18672.
Nour M.A., Kulikova A.V., Wanjohi J., El-Deeb A. Distinguishing High from Low Concentrations of RNA Cancer Marker: Five-Input DNAzyme Thresholding Gate. ChemistrySelect. 2023. Vol. 8. No. 48. pp. e202303011.
Patra C., Eldeeb A.A. Thresholding DNA nanomachine as a highly cooperative and efficient enzyme-like system for controlled RNA cleavage. ChemMedChem. 2023. Vol. 18. No. 7. pp. e202300040.
ГИБЕЛЬ КЛЕТОК АДЕНОКАРЦИНОМЫ ЯИЧНИКА ПОД ВОЗДЕЙСТВИЕМ АНТИСМЫСЛОВЫХ ОЛИГОНУКЛЕОТИДОВ
Towards DNA-robot for Auto Diagnosis and Cancer Treatment
ДНК-МАШИНЫ НА ОСНОВЕ БИНАРНЫХ ДЕЗОКСИРИБОЗИМОВ КАК ПЕРСПЕКТИВНЫЙ ИНСТРУМЕНТ БЕЗАМПЛИФИКАЦИОННОЙ ДИАГНОСТИКИ SARS-CoV-2
Development of DNA-based Machines for Selective Detection of Cancer-associated RNA
Использование триазиниламидофосфата для внутриклеточной доставки АСО и сложных ДНК-конструкций//OpenBio
АКТИВАЦИЯ БИНАРНЫМИ АНТИСМЫСЛОВЫМИ ОЛИГОНУКЛЕОТИДАМИ ДЕГРАДАЦИИ МРНК-МИШЕНИ С ПОМОЩЬЮ KRAS ТРАНСКРИПТА В КЛЕТОЧНОЙ ЛИНИИ K562 *
ANTISENSE OLIGONUCLEOTIDES RELEASING CASSETTE FOR CANCER THERAPY
Development and optimization of high affinity oncogene-specific DNA aptamers for human cancer cells binding
Genotyping of Cancer-associated KRAS Mutation by Deoxyribozyme Based 4-arms DNA Machine
МНОГОЯДЕРНАЯ ДНК-МАШИНА НА ОСНОВЕ БИНАРНЫХ ДЕЗОКСИРИБОЗИМОВ ДЛЯ БЕЗАМПЛИФИКАЦИОННОЙ ДЕТЕКЦИИ SARS-COV-2
Cancer cell death induced by antisense oligonucletides
MULTICORE DNA-MACHINE BASED ON BINARY DEOXYRIBOZYME FOR AMPLIFICATION-FREE DETECTION OF SARS-COV-2
DEPENDENCE OF THE AFFINITY OF OLIGONUCLEOTIDES ON CHEMICAL MODIFICATIONS AND THE LENGTH OF NUCLEOTIDE SEQUENCES
ADVANCING DNA AUTOMATION: MIRNAS-REGULATED “NOT-GATE” LOGIC ELEMENTS BASED ON DEOXYRIBOZYME DNA MACHINES
ДНК-МАШИНА С НЕСКОЛЬКИМИ КАТАЛИТИЧЕСКИМИ ЦЕНТРАМИ НА ОСНОВЕ ДЕЗОКСИРИБОЗИМА ДЛЯ БЕЗАМПЛИФИКАЦИОННОГО ДЕТЕКТИРОВАНИЯ SARS-COV-2
Prospects of using binary deoxyribozymes as a biosensor for quantitative analysis of oligonucleotide concentrations
РАЗРАБОТКА СЕЛЕКТИВНОЙ ДНК КОНСТРУКЦИИ С ПОРОГОВОЙ ЛОГИКОЙ ДЛЯ РАСЩЕПЛЕНИЯ МАТРИЧНОЙ РНК GFP
РАЗРАБОТКА МОДИФИЦИРОВАННОГО БИНАРНОГО АНТИСМЫСЛОВОГО НУКЛЕОТИДА ДЛЯ РАСЩЕПЛЕНИЯ ЦЕЛЕВОЙ мРНК В ПРИСУТСТВИИ ОНКОМАРКЕРА
AN shRNA RELEASING DNA NANOSTRUCTURE WITH ONCOMARKER-DEPENDENT ACTIVATION
NUCLEIC ACID BASED CONSTRUCTIONS FOR WIDE RANGE OF APPLICATIONS
ДНК МАШИНА С НЕСКОЛЬКИМИ КАТАЛИТИЧЕСКИМИ ЦЕНТРАМИ НА ОСНОВЕ ДЕЗОКСИРИБОЗИМА ДЛЯ БЕЗАМПЛИФИКАЦИОННОЙ ДЕТЕКЦИИ SARS-COV-2
КОНСТРУКЦИИ НА ОСНОВЕ НУКЛЕИНОВЫХ КИСЛОТ ДЛЯ ШИРОКОГО СПЕКТРА ПРИМЕНЕНИЙ
ОСОБЕННОСТИ ДИЗАЙНА БИНАРНЫХ АНТИСМЫСЛОВЫХ ОЛИГОНУКЛЕОТИДНЫХ АГЕНТОВ (БИАСО) ДЛЯ МАРКЕР-ЗАВИСИМОЙ АКТИВАЦИИ ТЕРАПЕВТИЧЕСКОЙ ФУНКЦИИ
РАЗРАБОТКА ЛОГИЧЕСКОГО ВЕНТИЛЯ «INHIBIT GATE» НА ОСНОВЕ БИНАРНОГО ДЕЗОКСИРИБОЗИМА
INVESTIGATION OF INTRACELLULAR DELIVERY OF THERAPEUTIC NUCLEIC ACIDS WITH THE HELP OF LIPID CONJUGATES AND DNA NANOSTRUCTURES
DETECTION OF NUCLEIC ACID BASED CANCER MARKERS INSIDE THE CELL
ANTENNA-EQUIPPED DEOXYRIBOZYME MACHINE FOR ULTRA-SENSITIVITY AMPLIFICATION-FREE DETECTION OF SARS-COV-2 RNA
Binary antisense constructs modulated by the concentration of cancer markers
Rubel M.S., Zablotskay S., Pokatova O., El-Deeb A.A., Ateiah M.G., Gorbenko D.A., Shkodenko L., Kolpashchikov D.M. DNA-nanomachines for nucleic acid detection. Bioinformatics of Genome Regulation and Structure/Systems Biology (BGRS/SB-2022) Novosibirsk, 04-08 июля 2022 г.. 2022. pp. 355-356.
El-Deeb A., Zablotskaya S., Rubel M.S., Nour M., Kozlovskaya L., Shtro A., Komissarov A., Kolpashchikov D.M. Toward a Home Test for COVID-19 Diagnosis: DNA Machine for Amplification-Free SARS-CoV-2 Detection in Clinical Samples. ChemMedChem. 2022. Vol. 17. No. 20. pp. e202200382.
ANTENNA-EQUIPPED DEOXYRIBOZYME-BASED DNA MACHINE FOR ULTRA -SENSITIVITY DETECTION OF SARS-COV-2 RNA
DESIGN OF A DNA MACHINE BASED ON SHRNA FOR MARKER-DEPENDENT RNA INTERFERENCE
ИССЛЕДОВАНИЕ БИНАРНЫХ АНТИСМЫСЛОВЫХ ОЛИГОНУКЛЕОТИДОВ СПЕЦИФИЧНЫХ К ОДНОНУКЛЕОТИДНОМУ ПОЛИМОРФИЗМУ МАРКЕРНОЙ ПОСЛЕДОВАТЕЛЬНОСТИ
MARKER INDUCED CLEAVAGE OF A TARGETED mRNA USING THE ANTISENSE OLIGONUCLEOTIDE-RELEASING CASSETTE (ASO-RC)
Drozd V.S., Eldeeb A.A., Kolpashchikov D.M., Nedorezova D.D. Binary antisense oligonucleotide agent for cancer marker-dependent degradation of targeted RNA. Nucleic Acid Therapeutics. 2022. Vol. 32. No. 5. pp. 412-420.
DEVELOPMENT OF PROTECTIONS FOR ANTISENSE AND BINARY ANTISENSE AGENTS
BINARY ANTISENSE OLIGONUCLEOTIDES FOR ONCOMARKER-DEPENDENT TARGET RNA DEGRADATION
ADVANCED DNA MACHINE FOR THE AMPLIFICATION FREE DETECTION OF SARS-HCOV-2 IN THE CLINICAL SAMPLES
COOPERATIVITY FOR CANCER TREATMENT: A THRESHOLDING DNA LOGIC GATE THAT IS ACTIVE AT HIGH CONCENTRATIONS OF CANCER MARKER RNA
DNA-constructs based on binary antisense technology towards selective gene therapy
DISTINGUISHING HIGH FROM LOW CONCENTRATIONS OF RNA CANCER MARKER: 5-INPUT BINARY DEOXYRIBOZYME THRESHOLDING GATE
DNA-constructs based on binary antisense technology towards selective gene therapy
Gomes de Oliveira A., Dubovichenko M.V., Eldeeb A.A., Wanjohi J., Zablotskaya S., Kolpashchikov D.M. RNA-Cleaving DNA Thresholder Controlled by Concentrations of miRNA Cancer Marker. ChemBioChem. 2021. Vol. 22. No. 10. pp. 1750-1754.
DNA Machine for SARS-COV-2 Detection in the Clinical Samples
Эльдиб А.А., Заблоцкая С.С., Рубель М.С., Комиссаров А.Б., Колпащиков Д.М. ДНК-машина для определения nCOV-SARS-2019. Современные достижения химико-биологических наук в профилактической и клинической медицине: сборник научных трудов Всероссийской научно-практической конференции с международным участием (СПб, 3декабря 2020г.). 2020. Т. Часть 1. С. 358-363.
ДНК-машина для определения nCOV-SARS-2019
ДНК-машина для определения nCOV-SARS-2019